14-day Premium Trial Subscription Try For FreeTry Free
Cardiovascular Systems' (CSII) ECLIPSE clinical trial data is likely to help physicians form an optimal treatment plan for patients with severely calcified coronary arteries.
Tough competition and consistent net loss continue to pose threats to Cardiovascular Systems (CSII).
Abbott Laboratories expands its cardiovascular pipeline with the relatively small acquisition of Cardiovascular Systems, Inc. Cardiovascular Systems investors get a way out of a cash-burning stock at
Abbott (NYSE: ABT) is buying Cardiovascular Systems (CSI). These are the details.
With the announcement of the merger agreement with Abbott, Cardiovascular Systems (CSII) refrains from providing any update on the 2023 guidance.

Why Cardiovascular Systems Stock Is Soaring Today

11:59am, Thursday, 09'th Feb 2023
The medtech company has agreed to a buyout offer from Abbott Laboratories.
Cardiovascular Systems (NASDAQ: CSII ) stock is rising higher on Thursday following news that Abbott (NYSE: ABT ) intends to acquire the company. That deal has Abbott offering to buy Cardiovascular Sy
Cardiovascular Systems CSII, -1.99% shares rose 47% to $19.58 in early premarket trade after Abbott ABT, -1.60% agreed to buy the company for $890 million, or $20 per share. CSI is a leader in devices
Cardiovascular Systems (CSII) delivered earnings and revenue surprises of -33.33% and 2.70%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the sto
Cardiovascular Systems (CSII) international revenues are showing strong growth in each of the key markets, including Japan, Europe, Asia Pacific and Canada.
The launch of the Scoreflex scoring balloon receives a positive response and generates over $1.7 million in sales during the first quarter for Cardiovascular Systems (CSII).
Cardiovascular Systems, Inc. (NASDAQ:CSII ) Q1 2023 Results Conference Call November 3, 2022 9:00 AM ET Company Participants Jack Nielsen - Vice President of Investor Relations Scott Ward - Chairman,
Cardiovascular Systems (CSII) delivered earnings and revenue surprises of -12.50% and 0.58%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the st
Cardiovascular Systems (CSII) reported earnings 30 days ago. What's next for the stock?
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE